RECRUITING

Diagnosing and Treating Low Blood Sugar Levels

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Hypoglycemia is the term used to refer to lower than normal levels of blood sugar. This study will continue to research the causes of hypoglycemia. Patients involved in the study will be admitted to the Clinical Center of the National Institutes of Health and undergo tests for evaluating blood sugar. Patients will be required to refrain from eating for a set period of time and will undergo blood tests for insulin levels and several other specific diagnostic tests related to insulin secretion. The patients will be under supervision and will be provided with appropriate medical and surgical attention as needed.

Official Title

Fasting Hypoglycemia: Diagnosis and Treatment

Quick Facts

Study Start:1991-05-21
Study Completion:N/A
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT00001276

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 120 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Male, females ages \>= 18.
  2. 2. Patients with documented fasting blood glucose below 55 mg/dl.
  1. 1. Patients with significant cardiac disease will be excluded.
  2. 2. Subjects who are pregnant per self-report.
  3. 3. Medically unstable per the assessment of the PI.

Contacts and Locations

Study Contact

Craig S Cochran, R.N.
CONTACT
(301) 402-1880
craigc@bdg10.niddk.nih.gov
Ranganath Muniyappa, M.D.
CONTACT
(301) 451-7702
muniyapr@mail.nih.gov

Principal Investigator

Ranganath Muniyappa, M.D.
PRINCIPAL_INVESTIGATOR
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Study Locations (Sites)

National Institutes of Health Clinical Center
Bethesda, Maryland, 20892
United States

Collaborators and Investigators

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

  • Ranganath Muniyappa, M.D., PRINCIPAL_INVESTIGATOR, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date1991-05-21
Study Completion DateN/A

Study Record Updates

Study Start Date1991-05-21
Study Completion DateN/A

Terms related to this study

Keywords Provided by Researchers

  • Hypoglycemia
  • Insulinoma
  • Natural History

Additional Relevant MeSH Terms

  • Hypoglycemia
  • Insulinoma